Biogen Inc

Stock Chart, Company Information, and Scan Results

$183.22(as of Mar 31, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Biogen Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$183.22
Ticker SymbolBIIB
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees7,500
CountyUSA
Market Cap$27,527.5M
EBIDTA3,603.7M
10-Day Moving Average184.97
P/E Ratio20.79
20-Day Moving Average185.74
Forward P/E Ratio11.56
50-Day Moving Average185.56
Earnings per Share8.80
200-Day Moving Average158.73
Profit Margin-2.12%
RSI46.80
Shares Outstanding146.8M
ATR5.99
52-Week High202.41
Volume2,641,577
52-Week Low110.04
Most Recent Support Level183.01
Book Value18,256.8M
Most Recent Resistance Level192.28
P/B Ratio1.47
Upper Keltner199.21
P/S Ratio2.74
Lower Keltner172.27
Debt-to-Equity Ratio199.21
Next Earnings Date05/06/2026
Cash Surplus-340.9M
Next Ex-Dividend DateUnknown

Biogen has discovered, developed, and delivered breakthrough treatments for nearly half a century. This neuro-STAR has dedicated itself to unlocking the secrets of the brain with a focus on treatments for neurological and neurodegenerative diseases. Its diverse portfolio of products includes a multiple sclerosis drug and a recently FDA-approved Alzheimer's disease treatment.

Biogen Inc In Our Stock Scanner

As of Apr 01, 2026
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.